Details for New Drug Application (NDA): 207507
✉ Email this page to a colleague
The generic ingredient in ALPRAZOLAM is alprazolam. There are fifteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Summary for 207507
Tradename: | ALPRAZOLAM |
Applicant: | Chartwell Rx |
Ingredient: | alprazolam |
Patents: | 0 |
Suppliers and Packaging for NDA: 207507
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALPRAZOLAM | alprazolam | TABLET;ORAL | 207507 | ANDA | Calvin Scott & Co., Inc. | 17224-624 | 17224-624-28 | 28 TABLET in 1 BOTTLE (17224-624-28) |
ALPRAZOLAM | alprazolam | TABLET;ORAL | 207507 | ANDA | medsource pharmaceuticals | 45865-972 | 45865-972-30 | 30 TABLET in 1 BOTTLE (45865-972-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.25MG | ||||
Approval Date: | Jul 9, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Jul 9, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Jul 9, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription